(Q42616085)

3 November 2017

Clodronate as a single-dose intravenous infusion effectively provides short-term correction of malignant hypercalcemia (English)

1 reference

3 November 2017

Jaakko I Nevalainen

3

0 references

author name string

Sari T Atula

series ordinal

1

1 reference

PubMed ID

14690159

3 November 2017

Riitta K Tähtelä

series ordinal

2

1 reference

PubMed ID

14690159

3 November 2017

Liisa H Pylkkänen

series ordinal

4

1 reference

3 November 2017

1 January 2003

1 reference

3 November 2017

1 reference

3 November 2017

42

1 reference

3 November 2017

735-740

1 reference

3 November 2017

7

1 reference

Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis

3 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F02841860310013111

Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310013111

Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310013111

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310013111

Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310013111

Tumour induced hypercalcaemia: a case for active treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310013111

Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310013111

Clodronate. A randomized study in the treatment of cancer-related hypercalcemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310013111

Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases--a prospective randomised placebo-controlled multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310013111

10.1080/02841860310013111

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference

PubMed ID

14690159